Laird Norton Wetherby Wealth Management, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 327 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Laird Norton Wetherby Wealth Management, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2022$221,000
+7.8%
2,907
-1.2%
0.02%
+14.3%
Q2 2022$205,000
-8.1%
2,943
+9.1%
0.01%
+7.7%
Q1 2022$223,000
+2.8%
2,697
-6.6%
0.01%
+8.3%
Q4 2021$217,000
-31.1%
2,887
+6.3%
0.01%
-36.8%
Q3 2021$315,000
-49.6%
2,715
-3.7%
0.02%
-50.0%
Q2 2021$625,000
+92.9%
2,818
+14.9%
0.04%
+52.0%
Q1 2021$324,000
-29.3%
2,452
-7.3%
0.02%
-19.4%
Q4 2020$458,000
+82.5%
2,646
+17.2%
0.03%
+40.9%
Q3 2020$251,0002,2580.02%
Other shareholders
NOVOCURE LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders